Publications of Tiago F. Outeiro
All genres
Journal Article (101)
81.
Journal Article
26 (12), pp. 2231 - 2246 (2017)
Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage. Human Molecular Genetics 82.
Journal Article
114 (25), pp. E4971 - E4977 (2017)
Treatment with diphenyl-pyrazole compound anle138b/c reveals that alpha-synuclein protects melanoma cells from autophagic cell death. Proceedings of the National Academy of Sciences of the United States of America 83.
Journal Article
114 (25), pp. E4971 - E4977 (2017)
Treatment with diphenyl–pyrazole compound anle138b/c reveals that α-synuclein protects melanoma cells from autophagic cell death. Proceedings of the National Academy of Sciences of the United States of America 84.
Journal Article
140, pp. 1399 - 1419 (2017)
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies. Brain 85.
Journal Article
140, pp. 878 - 886 (2017)
The yin and yang of α-synuclein-associated epigenetics in Parkinson's disease. Brain 86.
Journal Article
15 (3), e1002601 (2017)
The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease. PLoS Biology 87.
Journal Article
7, 42942 (2017)
Alpha-synuclein prevents the formation of spherical mitochondria and apoptosis under oxidative stress. Scientific Reports 88.
Journal Article
26 (19), pp. 3763 - 3775 (2017)
Protein phosphatase 1 regulates huntingtin exon 1 aggregation and toxicity. Human Molecular Genetics 89.
Journal Article
37, pp. 121 - 131 (2017)
Cellular uptake of α-Synuclein oligomer-selective antibodies is enhanced by the extracellular presence of α-Synuclein and mediated via Fcγ receptors. Cellular and Molecular Neurobiology 90.
Journal Article
40, pp. 168 - 181 (2017)
Cell reprogramming: Therapeutic potential and the promise of rejuvenation for the aging brain. Ageing Research Reviews 91.
Journal Article
4, 128 (2016)
The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation. Acta Neuropathologica Communications 92.
Journal Article
6, 36798 (2016)
Glycation potentiates neurodegeneration in models of Huntington's disease. Scientific Reports 93.
Journal Article
113 (42), pp. E6506 - E6515 (2016)
Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity. Proceedings of the National Academy of Sciences of the United States of America 94.
Journal Article
434, pp. 238 - 249 (2016)
Distinct roles of N-acetyl and 5-methoxy groups in the antiproliferative and neuroprotective effects of melatonin. Molecular and Cellular Endocrinology 95.
Journal Article
6, 31493 (2016)
The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. Scientific Reports 96.
Journal Article
25 (14), pp. 2959 - 2971 (2016)
A familial ATP13A2 mutation enhances alpha-synuclein aggregation and promotes cell death. Human Molecular Genetics 97.
Journal Article
12 (6), e1006098 (2016)
C-terminal tyrosine residue modifications modulate the protective phosphorylation of Serine 129 of α-synuclein in a yeast model of Parkinson's disease. PLoS Genetics 98.
Journal Article
31 (6), pp. 782 - 790 (2016)
Glycation in Parkinson's disease and Alzheimer's disease. Movement Disorders 99.
Journal Article
12, e1005995 (2016)
shRNA-based screen identifiers endocytic recycling pathway components that act as genetic modifiers of alpha-synuclein aggregation, secretion and toxicity. PLoS Genetics 100.
Journal Article
25 (2), pp. 275 - 290 (2016)
Yeast reveals similar molecular mechanisms underlying alpha- and beta-synuclein toxicity. Human Molecular Genetics